Difference between revisions of "Talk:Gnaiger 2020 BEC MitoPathways"
From Bioblast
| Line 1: | Line 1: | ||
== 2020 5th edition == | == 2020 5th edition == | ||
::: '''Current updates''' | ::: '''Current updates''' (2020-12-28) | ||
::::* Section 8.4 | ::::* Section 8.3.4. Measurement of the ''pmF'' - updated | ||
::::* | ::::* Sections 8.4.3 and 8.4.4 - updated with modified symbols | ||
: | :# Real-time OXPHOS analysis - [[File:C1-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-26) | ||
: | :# Respiratory states and rates: coupling control - [[File:Chapter 2-MitoPathways.pdf]] (last update 2020-12-02) | ||
: | :# Normalization of rate: flow, flux, and flux control efficiencies - [[File:C3-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-02) | ||
: | :# NADH-linked pathways through Complex I: respiratory pathway control with pruvate, glutamate, malate - [[File:C4-MitoPathways_BEC_2020.2.pdf]] (last update 2020-12-08) | ||
: | :# S-pathway through Complex CII, F-pathway through electron-transferring flavoprotein, Gp-pathway through glycerophosphate dehydrogenase - [[File:C5-MitoPathways BEC 2020.2.pdf]] (last update 2020-11-17) | ||
: | :# NS-pathway through Complexes CI & CII: convergent electron transfer at the Q-junction and additive effect of substrate combinations - [[File:C6-MitoPathways_BEC_2020.2.pdf]] (last update 2020-12-03) | ||
: | :# Additivity of convergent electron transfer - [[File:C7-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-04) | ||
: | :# Protonmotive pressure and respiratory control - [[File:C8-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-28) | ||
:» A. Conversions of metabolic fluxes - [[File:SA-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-26) | |||
:» B. Substrates, uncouplers, inhibitors - SUIT - [[File:SB-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-21) | |||
::» A. Conversions of metabolic fluxes - [[File:SA-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-26) | |||
::» B. Substrates, uncouplers, inhibitors - SUIT - [[File:SB-MitoPathways BEC 2020.2.pdf]] (last update 2020-12-21) | |||
Revision as of 13:09, 28 December 2020
2020 5th edition
- Current updates (2020-12-28)
- Section 8.3.4. Measurement of the pmF - updated
- Sections 8.4.3 and 8.4.4 - updated with modified symbols
- Current updates (2020-12-28)
- Real-time OXPHOS analysis - File:C1-MitoPathways BEC 2020.2.pdf (last update 2020-12-26)
- Respiratory states and rates: coupling control - File:Chapter 2-MitoPathways.pdf (last update 2020-12-02)
- Normalization of rate: flow, flux, and flux control efficiencies - File:C3-MitoPathways BEC 2020.2.pdf (last update 2020-12-02)
- NADH-linked pathways through Complex I: respiratory pathway control with pruvate, glutamate, malate - File:C4-MitoPathways BEC 2020.2.pdf (last update 2020-12-08)
- S-pathway through Complex CII, F-pathway through electron-transferring flavoprotein, Gp-pathway through glycerophosphate dehydrogenase - File:C5-MitoPathways BEC 2020.2.pdf (last update 2020-11-17)
- NS-pathway through Complexes CI & CII: convergent electron transfer at the Q-junction and additive effect of substrate combinations - File:C6-MitoPathways BEC 2020.2.pdf (last update 2020-12-03)
- Additivity of convergent electron transfer - File:C7-MitoPathways BEC 2020.2.pdf (last update 2020-12-04)
- Protonmotive pressure and respiratory control - File:C8-MitoPathways BEC 2020.2.pdf (last update 2020-12-28)
- » A. Conversions of metabolic fluxes - File:SA-MitoPathways BEC 2020.2.pdf (last update 2020-12-26)
- » B. Substrates, uncouplers, inhibitors - SUIT - File:SB-MitoPathways BEC 2020.2.pdf (last update 2020-12-21)
2014 4th edition
- The 4th edition was released at MiP2014 and IOC95, with a new chapter on coupling control and updated terminology on respiratory states, including an overview on flux control factors. Suggestions on corrections and improvements are highly appreciated: Email to: [email protected]
Feedback
- It was a delight to meet you at UMDF in Pittsburgh and a delight to read your “Blue Book.” As a scientist re-learning mitochondriology, the Blue Book was extremely helpful, as is your Bioblast Glossary. You and Oroboros are doing a significant service to the scientific community! - Peter J. Oates (2014-07-08), Ph.D., Sr. Director, Research, Stealth Peptides Inc., Newton, MA 02466, USA. [email protected] - www.linkedin.com/oatespj
- Thank you for the "Blue book"! I was surprised when I found the conference 2013 book with the Blue book [...] and I felt disappointed because I couldn't attend the conference... This book is full of interesting topics, lectures and abstracts! - Igor Golic (2014), University of Belgrade, Cell and Tissue Biology Dept., RS.
Popular Bioblast page
- Gnaiger 2019 MitoPathways has been accessed more than
- 55,000 times (2019-12-12)
- 50,000 times (2019-07-22)
- 45,000 times (2019-03-13)
- 40,000 times (2018-10-18)
- 35,000 times (2017-06-24)
- 30,000 times (2016-10-07)
- 25,000 times (2016-04-03)
- 20,000 times (2015-12-15)
- 15,000 times (2015-08-11)
- 10,000 times (2015-01-09)
- 5,000 times (2014-06-22)
- Gnaiger 2019 MitoPathways has been accessed more than
